2024 Early Hearing Detection & Intervention Conference
March 17-19, 2024 • Denver, CO
3/06/2023 | 11:30 AM - 12:00 PM | Implementation of Virginia’s Hearing Targeted cCMV Screening Program | DECC 211
Implementation of Virginia’s Hearing Targeted cCMV Screening Program
In 2019, the VA EHDI program was tasked with the implementation of hearing targeted congenital Cytomegalovirus (cCMV) screening, which was implemented on September 1, 2020. VA EHDI had assistance from various stakeholders in development of cCMV legislation and protocols.
The months prior to implementation were during the height of the COVID-19 pandemic, resulting in difficulty for conducting training sessions due to travel restrictions and hospital accessibility for VA EHDI staff. The VA EHDI program shifted focus from on-site educational site visits and developed virtual training sessions for birthing hospitals to maximize education of external stakeholders. In order to reach various stakeholders with travel restrictions in place, VA EHDI leveraged stakeholders from various parts of the state including Infectious Disease specialists, Otolaryngologists, Primary Care Providers (PCPs), Neonatologists, Audiologists and parents to assist in training and education.
Additionally, in Spring 2021, VA EHDI obtained feedback that PCPs were not adequately educated prior to implementation. In order to address these concerns, VA EHDI collaborated with engaged stakeholders to develop materials for PCPs, including: “Assessment and Management of Congenital Cytomegalovirus” and “When to screen for cCMV.” VA EHDI also collaborated with the Virginia American Academy of Pediatrics (VA AAP) and a major health system in Virginia to develop a training session for PCPs.
In this session, we will highlight VA EHDI program’s experience with the development of regulations, protocols, and training for targeted cCMV screening. An Infectious Disease specialist will discuss her role in the process of implementation. We will review the process for conducting screening and necessary follow-up. Additionally, we will share lessons learned with changes identified after implementation, including steps taken to address these concerns, continuous quality improvement (CQI) metrics, and ongoing education needs. We hope this session will serve as a guidance for states wishing to develop and implement cCMV screening.
- development of regulations, protocols, and training for targeted cCMV screenin
- share lessons learned with changes identified after implementation, including steps taken to address these concerns, continuous quality improvement (CQI) metrics,
- serve as a guidance for states wishing to develop and implement cCMV screening
Presentation:
3420032_15626RebeccaLevorson.pdf
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Deepali Sanghani
(Primary Presenter,Co-Presenter,Author), Virginia Early Hearing Detection and Intervention Program, deepali.sanghani@vdh.virginia.gov;
Deepali Sanghani is the CMV Follow-Up Coordinator for the Virginia Department of Health, Virginia Early Hearing Detection and Intervention (VA EHDI) Program. Deepali has a Bachelors of Science in Psychology and a Masters in Public Health. Deepali has worked in Public Health for over 5 years and has a passion for helping others. In her role with VA EHDI, she oversees hearing screening and cCMV screening follow-up. In her spare time Deepali enjoys reading, listening to music and spending time with family and friends. Deepali resides in Richmond, Virginia with her husband and two daughters.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Parker Brodsky
(Co-Presenter,Author), VA EHDI, Parker.Brodsky@vdh.virginia.gov;
Parker Brodsky is the Newborn Screening Epidemiologist for the Virginia Department of Health Division of Population Health Data. Parker has a Bachelor of Arts in Global Public Health and a Masters in Public Health. In her role as an epidemiologist, she analyzes trends in data for VA EHDI to inform programmatic decision making. Parker lives in Richmond Virginia and enjoys reading, painting, and finding new restaurants.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Daphne Miller
(Author,Co-Author), Virginia EHDI, daphne.miller@vdh.virginia.gov;
Daphne Miller is currently the Early Hearing Detection & Intervention Coordinator for the Virginia Department of Health. The VA EHDI Program ensures all infant's hearing is screened at birth and if children are diagnosed with hearing loss they are referred to Early Intervention. Daphne has a Bachelor of Science in Business Administration and has worked with families and children over 15 years. In her spare time she enjoys binge watching shows, listening to music and spending time with family and friends. Daphne resides in Richmond, Virginia with her husband and daughter.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Christen Crews
(Author,Co-Author), Virginia Department of Health, christen.crews@vdh.virginia.gov;
Christen Crews, MSN, RN, is the Newborn Screening and Birth Defects Surveillance Programs Manager for the Virginia Department of Health (VDH). She has over 20 years of leadership experience, with 9 years specifically focusing on newborn screening. She has an established passion for public health as evidenced by current and past dedication to program development, education, and management of the Dried Blood Spot (DBS) Newborn Screening (NBS), Critical Congenital Heart Disease (CCHD) and Sickle Cell Disease, Early Hearing Intervention and Detection (VA EHDI), Rare Disease Council, and Birth Defects Surveillance (BDS) programs in Virginia. She is a leader of change with documented successful outcomes of quality improvements by designing, integrating, troubleshooting, and providing training on new technology to revolutionize NBS-DBS critical reporting, follow-up, and communication across the Commonwealth of Virginia with national recognition.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Rebecca Levorson
(Co-Presenter,Co-Author), INOVA Children's Infectious Diseases, rebecca.levorson@inova.org;
Rebecca Levorson, MD, Pediatric Infectious Diseases Physician. Dr. Levorson is the Division Director for Pediatric Infectious Diseases at Inova Children’s Hospital, Fairfax, VA. In addition to working clinically, she has worked in the realm of hospital epidemiology and antimicrobial stewardship for the past dozen years at Inova Fairfax Medical Campus. She is an eager teacher and mentor of trainees as she hopes to have excellent replacements for herself when she finally retires.
She has worked with the VA Department of Health on many infectious disease issues including congenital Zika virus evaluation, congenital cytomegalovirus infection, and a seroprevalence project of COVID-19 in children of Northern Virginia. She is interested in congenital infections, emerging infectious diseases, and antimicrobial stewardship.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -